Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Glucose Control”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05504226
What this trial is testing

Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and Metformin

Who this might be right for
Type 2 Diabetes
Handok Inc. 214
Large-scale testing (Phase 3)Ended earlyNCT04606576
What this trial is testing

Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Oramed, Ltd. 710
Large-scale testing (Phase 3)Study completedNCT01734785
What this trial is testing

Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 607
Large-scale testing (Phase 3)Study completedNCT00790205
What this trial is testing

Sitagliptin Cardiovascular Outcomes Study (MK-0431-082)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 14,671
Testing effectiveness (Phase 2)Study completedNCT00631488
What this trial is testing

Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015)

Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 146
Large-scale testing (Phase 3)Study completedNCT04356742
What this trial is testing

Efficacy and Safety of Dapagliflozin When Added to Ongoing Metformin and Evogliptin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Who this might be right for
Type 2 Diabetes
Dong-A ST Co., Ltd. 198
Large-scale testing (Phase 3)Study completedNCT02036515
What this trial is testing

Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 464
Large-scale testing (Phase 3)Study completedNCT02489968
What this trial is testing

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 880
Large-scale testing (Phase 3)Study completedNCT00395343
What this trial is testing

Sitagliptin Added-on to Insulin Study (0431-051)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 641
Large-scale testing (Phase 3)Study completedNCT02453555
What this trial is testing

Empagliflozin Add on to Linagliptin Study in Japanese Patient With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 275
Not applicableStudy completedNCT04847778
What this trial is testing

Assess the Impact of Insulclock on Glycemic Variability and Treatment Compliance in Uncontrolled DM1 Patients

Who this might be right for
Diabetes Mellitus, Type 1
Hospital General de Segovia 80
Post-approval studies (Phase 4)Study completedNCT02338921
What this trial is testing

Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination Therapy

Who this might be right for
Type 2 Diabetes
Seoul National University Bundang Hospital 78
Testing effectiveness (Phase 2)Study completedNCT00618007
What this trial is testing

Effect of PF-00734200 in Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 289
Large-scale testing (Phase 3)Study completedNCT00240370
What this trial is testing

Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics

Who this might be right for
Type 2 Diabetes
Bristol-Myers Squibb 1,159
Large-scale testing (Phase 3)Study completedNCT01958671
What this trial is testing

The Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 461
Large-scale testing (Phase 3)Study completedNCT01590771
What this trial is testing

A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-253)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 498
Large-scale testing (Phase 3)Study completedNCT00698932
What this trial is testing

Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic Control

Who this might be right for
Type 2 Diabetes
AstraZeneca 568
Large-scale testing (Phase 3)Study completedNCT01306214
What this trial is testing

Safety and Efficacy of BI 10773 as add-on to Insulin Regimen in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2Obesity
Boehringer Ingelheim 566
Large-scale testing (Phase 3)Study completedNCT02531035
What this trial is testing

Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone

Who this might be right for
Type 1 Diabetes Mellitus (T1DM)High Level of Sugar (Glucose) in the Blood
Lexicon Pharmaceuticals 1,405
Post-approval studies (Phase 4)Study completedNCT00833027
What this trial is testing

ALPHA Sitagliptin Add on to Metformin (0431-103)

Who this might be right for
Diabetes Mellitus
Merck Sharp & Dohme LLC 608
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation